Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Disease to Bone”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)WithdrawnNCT00117260
What this trial is testing

Study to Evaluate the Safety and Efficacy of Seasonale for Treatment of Low Bone Mineral Density

Who this might be right for
Osteopenia
Duramed Research
Testing effectiveness (Phase 2)Study completedNCT00802880
What this trial is testing

Dacarbazine for Metastatic Soft Tissue and Bone Sarcoma

Who this might be right for
Sarcoma
Washington University School of Medicine 80
Testing effectiveness (Phase 2)Study completedNCT00410813
What this trial is testing

S0622, Dasatinib in Treating Patients With Stage IV Breast Cancer That Has Spread to the Bone

Who this might be right for
Breast CancerMetastatic Cancer
SWOG Cancer Research Network 85
Not applicableStudy completedNCT04232761
What this trial is testing

Study to Gather Information on the Safety and How Radium-223 Dichloride, an Alpha Particle-emitting Radioactive Agent, Works Under Routine Clinical Practice in Taiwan in Patients With Castration-resistant Prostate Cancer (CRPC) Which Has Spread to the Bone

Who this might be right for
Castration-resistant Prostate Cancer
Bayer 194
Testing effectiveness (Phase 2)UnknownNCT03063983
What this trial is testing

Clinical Trial Evaluating Metronomic Chemotherapy in Patients With Metastatic Osteosarcoma

Who this might be right for
Osteosarcoma
Grupo de Apoio ao Adolescente e a Crianca com Cancer 158
Testing effectiveness (Phase 2)UnknownNCT00036712
What this trial is testing

Light-Emitting Diode Therapy in Preventing Mucositis in Children Receiving Chemotherapy With or Without Radiation Therapy Before Bone Marrow Transplantation

Who this might be right for
Chronic Myeloproliferative DisordersKidney CancerLeukemia+9 more
Medical College of Wisconsin 80
Post-approval studies (Phase 4)Ended earlyNCT02414698
What this trial is testing

Percutaneous HydroDiscectomy Compared to TESI for Radiculopathy

Who this might be right for
Lumbar Herniated Disc
Montefiore Medical Center 4
Not applicableActive Not RecruitingNCT06713941
What this trial is testing

Management of Bone Metastases

Who this might be right for
CancerBone Metastases
Hospices Civils de Lyon 900
Not applicableLooking for participantsNCT06529549
What this trial is testing

Efficacy and Safety of Organoid-Based Drug Sensitivity Screening to Guide the Treatment of mCRPC Patients Progressed After First-line Treatment

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
Sun Yat-sen University 30
Not applicableLooking for participantsNCT04796350
What this trial is testing

RESTORE - Study of AGN1 LOEP to Prevent Secondary Hip Fractures

Who this might be right for
Fragility FractureHip FracturesOsteoporosis
AgNovos Healthcare, LLC 2,400
Testing effectiveness (Phase 2)Ended earlyNCT00415584
What this trial is testing

Cinacalcet to Treat Hypercalcemia in Renal Transplant Recipients

Who this might be right for
Secondary HyperparathyroidismHypercalcemia
Montefiore Medical Center 4
Testing effectiveness (Phase 2)Ended earlyNCT03593915
What this trial is testing

A Phase 1b/2 Study of Alvocidib Plus Decitabine or Azacitidine in Patients With MDS

Who this might be right for
Myelodysplastic Syndromes (MDS)
Sumitomo Pharma America, Inc. 20
Large-scale testing (Phase 3)Study completedNCT00321464
What this trial is testing

A Study Comparing Denosumab vs. Zoledronic Acid for the Treatment of Bone Metastases in Breast Cancer Subjects.

Who this might be right for
Bone Metastases
Amgen 2,049
Post-approval studies (Phase 4)Ended earlyNCT00819832
What this trial is testing

Anderson Circulating Tumor Cell Burden (CTCB) Study

Who this might be right for
CancerSpinal DiseaseVertebral Compression Fractures
M.D. Anderson Cancer Center 3
Testing effectiveness (Phase 2)WithdrawnNCT02420587
What this trial is testing

AMG 208 Tumor Microenvironment in Metastatic Castration Resistant Prostate Cancer (mCRPC)

Who this might be right for
Prostate Cancer
M.D. Anderson Cancer Center
Not applicableEnded earlyNCT00900068
What this trial is testing

Blood Samples From Patients on a Clinical Trial to CINV During HSCT

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more
OHSU Knight Cancer Institute 9
Testing effectiveness (Phase 2)Looking for participantsNCT07043608
What this trial is testing

Zanzalintinib for Metastatic Clear Cell Renal Cell Carcinoma With Bone Metastases

Who this might be right for
Clear Cell Renal Cell Cancer (ccRCC)Clear Cell Renal CarcinomaClear Cell Renal Cell Carcinoma Metastatic+7 more
Kelly Fitzgerald, MD 20
Post-approval studies (Phase 4)Active Not RecruitingNCT04597125
What this trial is testing

RADIANT: A Study of Radium-223 Dichloride (Xofigo) vs Enzalutamide or Abiraterone (ARPIs, Androgen Receptor Pathway Inhibitors) in Patients With Prostate Cancer That Has Spread to the Bones (mCRPC, Metastatic Castration-Resistant Prostate Cancer)

Who this might be right for
Metastatic Castrate Resistant Prostate Cancer (mCRPC)
Bayer 654
Large-scale testing (Phase 3)Study completedNCT00172055
What this trial is testing

Study to Assess Efficacy and Safety of Zoledronic Acid and the Value of Markers of Bone Resorption in the Prediction of Bone Metastases and Cancer Treatment-induced Bone Loss (CTIBL) in Patients With Prostate Cancer on Hormone Therapy

Who this might be right for
Cancer Prostate
Novartis Pharmaceuticals 218
Not applicableLooking for participantsNCT06516406
What this trial is testing

Ruxolitinib in Primary Myelofibrosis and Secondary to Essential Thrombocythemia or Polycythemia Vera

Who this might be right for
MyelofibrosisPrimary MyelofibrosisSecondary Myelofibrosis
IRCCS Azienda Ospedaliero-Universitaria di Bologna 1,055
Next Page